UPDATED May 08, 2024
Discover large cap French Pharmaceuticals & Biotech companies that are on the CAC. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SAN | €93.08 | 0% | -5.8% | €116.2b | €108.06 | PE25.6x | E16.6% | 4.0% | ||
DIM | €204.40 | 0.7% | -17.3% | €19.9b | €251.33 | PE78.1x | E23.3% | 0.3% | ||
ERF | €57.62 | 0.03% | -6.1% | €11.1b | €60.88 | PE43.3x | E20.2% | 0.9% | ||
IPN | €116.80 | 2.4% | 4.6% | €9.6b | €125.53 | PE15.6x | E6.3% | 1.0% | ||
VIRP | €358.00 | 3.2% | 20.1% | €3.0b | €368.00 | PE24.7x | E11.2% | 0.4% | ||
VETO | €95.00 | 0.7% | 2.2% | €1.1b | €105.67 | PE20.2x | E4.8% | 0.9% | ||
ABVX | €13.46 | -2.6% | -16.9% | €846.9m | €37.59 | PS188.5x | E9.8% | n/a | ||
BOI | €33.85 | -1.3% | -14.3% | €587.7m | €39.60 | PE16.4x | E13.1% | 3.2% | ||
VLA | €3.25 | -3.7% | -41.6% | €451.6m | €8.97 | PS3x | E36.9% | n/a | ||
MEDCL | €14.84 | 3.3% | 84.8% | €426.6m | €17.15 | PS30.2x | E67.8% | n/a | ||
EAPI | €3.07 | 4.1% | -71.0% | €291.5m | €4.72 | PB0.3x | E85.2% | n/a | ||
NANO | €6.18 | 13.5% | 25.7% | €291.1m | €10.60 | PS8x | E6.5% | n/a | ||
ALCLS | €2.80 | 15.0% | 57.3% | €200.9m | n/a | PS23.5x | E56.2% | n/a | ||
ALSEN | €0.71 | 1.4% | 163.7% | €195.1m | €2.38 | PS35x | E42.8% | n/a | ||
IPH | €2.29 | 4.6% | -18.4% | €185.1m | €6.27 | PS3x | E33.0% | n/a | ||
AELIS | €13.00 | 0% | -7.1% | €170.7m | €20.67 | PS13.8x | E-43.4% | n/a | ||
IVA | €3.26 | 9.0% | 37.0% | €169.6m | €13.83 | PS7.3x | E17.6% | n/a | ||
GNFT | €3.37 | 4.0% | -11.3% | €167.5m | €9.38 | PS4.9x | E54.7% | n/a | ||
ALERS | €14.78 | 2.6% | -13.3% | €151.1m | €30.00 | PE31.5x | E36.3% | n/a | ||
OSE | €6.66 | 18.1% | 71.2% | €143.7m | €7.15 | PS64.5x | E92.9% | n/a | ||
TNG | €1.34 | 10.2% | -25.5% | €135.1m | €3.50 | PS17.1x | E-26.1% | n/a | ||
ADOC | €9.00 | 7.7% | 148.6% | €128.6m | €9.70 | PS21.3x | E104.5% | n/a | ||
DBV | €1.20 | -1.1% | -63.4% | €115.8m | €6.50 | PS8.3x | E-10.7% | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |